Intervention Review

Anticholinergics for urinary symptoms in multiple sclerosis

  1. Richard S Nicholas1,*,
  2. Tim Friede2,
  3. Sally Hollis3,
  4. Carolyn A Young4

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 29 JAN 2008

DOI: 10.1002/14651858.CD004193.pub2


How to Cite

Nicholas RS, Friede T, Hollis S, Young CA. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004193. DOI: 10.1002/14651858.CD004193.pub2.

Author Information

  1. 1

    Charing Cross Hospital, West London Neurosciences Centre, London, UK

  2. 2

    Warwick Medical School - University of Warwick, Health Sciences Research Institute, Coventry, UK

  3. 3

    University of Nottingham, c/o Cochrane Skin Group, Nottingham, UK

  4. 4

    The Walton Centre for Neurology and Neurosurgery, Liverpool, UK

*Richard S Nicholas, West London Neurosciences Centre, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. richard.nicholas@btinternet.com.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

  1. Current Version

    Anticholinergics for urinary symptoms in multiple sclerosis

    Richard S Nicholas, Tim Friede, Sally Hollis and Carolyn A Young

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD004193.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Anticholinergics for urinary symptoms in multiple sclerosis

    RS Nicholas, T Friede, S Hollis and CA Young

    Article first published online: 22 APR 2003 | DOI: 10.1002/14651858.CD004193